InvestorsHub Logo
Followers 1
Posts 25
Boards Moderated 0
Alias Born 03/26/2017

Re: None

Tuesday, 03/26/2019 1:13:40 PM

Tuesday, March 26, 2019 1:13:40 PM

Post# of 9955
PV-10 Trial Updated


This is the Stage 3 patient cohort expansion we've been waiting on.


"The Company will further expand the Phase 1b portion of the PV-10-pembrolizumab combination study to include a cohort of up to 24 patients who have satellite or in-transit disease (Stage IIIB/C/D melanoma). A first expansion cohort currently is enrolling up to 24 patients with advanced melanoma (Stage IV) who are refractory to checkpoint inhibition."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PVCT News